Barclays’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6
Closed -$11 – 5413
2026
Q2
$11 Buy
+6
New +$13 ﹤0.01% 5298
2021
Q2
– Sell
-9
Closed – – 4871
2021
Q1
$0 Sell
9
-2,991
-100% -$153K ﹤0.01% 4707
2020
Q4
$120K Sell
3,000
-1,825
-38% -$91.4K ﹤0.01% 4051
2020
Q3
$267K Sell
4,825
-1,438
-23% -$93K ﹤0.01% 3668
2020
Q2
$363K Buy
+6,263
New +$351K ﹤0.01% 3598
2018
Q4
– Sell
-7
Closed – – 6943
2018
Q3
$0 Buy
+7
New +$210 ﹤0.01% 7122

Other funds holding BMRA

Barclays's BMRA Position: Q3 2026 in Review

Barclays sold out of Biomerica (BMRA) in Q3 2026, closing a stake of 6 shares — an estimated $11 sold.

Barclays first reported a position in BMRA in Q3 2018 and held it in 6 quarters. The position peaked at $363K in Q2 2020. 21 funds tracked by Wall St. Rank hold BMRA as of Q3 2026.

  • Barclays reported no remaining Biomerica position as of Q3 2026 after selling out during the quarter.
  • Barclays sold 6 Biomerica shares in Q3 2026, an estimated $11.
  • Barclays first reported a position in Biomerica in Q3 2018 and held it in 6 quarters.
  • Barclays's Biomerica position peaked at $363K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Biomerica as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.